Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/45056
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorSánchez Caraballo, Jorge Mario-
dc.contributor.authorSánchez Caraballo, Andrés-
dc.contributor.authorMúnera Gómez, Marlon Gustavo-
dc.contributor.authorGarcía Gómez, Elizabeth-
dc.contributor.authorLópez Crespo, Juan Felipe-
dc.contributor.authorVelásquez Lopera, Margarita María-
dc.contributor.authorCardona Villa, Ricardo-
dc.date.accessioned2025-02-19T22:08:19Z-
dc.date.available2025-02-19T22:08:19Z-
dc.date.issued2021-
dc.identifier.citationSánchez J, Sánchez A, Munera M, Garcia E, Lopez JF, Velásquez-Lopera M, Cardona R. Presence of IgE Autoantibodies Against Eosinophil Peroxidase and Eosinophil Cationic Protein in Severe Chronic Spontaneous Urticaria and Atopic Dermatitis. Allergy Asthma Immunol Res. 2021 Sep;13(5):746-761. doi: 10.4168/aair.2021.13.5.746.spa
dc.identifier.issn2092-7355-
dc.identifier.urihttps://hdl.handle.net/10495/45056-
dc.description.abstractABSTRACT: Purpose: Eosinophils are frequently found in atopic dermatitis (AD) and chronic spontaneous urticaria (CSU) that release eosinophil peroxidase (EPX) and eosinophil cationic protein (ECP). Continuous exposure to these proteins could trigger an autoimmune response which may contribute to the pathogenesis and severity of skin inflammation. In this study, we investigate the immunoglobulin E (IgE) response against eosinophil proteins in CSU and AD. Methods: We recruited patients with severe AD, severe CSU and healthy subjects to explore the presence of IgE autoantibodies and cross-reactivity against EPX, ECP and thyroid peroxidase (TPO). The potential cross-reactive epitopes among the peroxidase family were determined using in silico tools. Results: The frequencies of anti-EPX IgE (28.8%) and anti-ECP IgE (26.6%) were higher in the AD group, and anti-TPO IgE was higher in the CSU group (27.2%). In the CSU group, there was a correlation between the anti-EPX IgE and anti-TPO IgE levels (r = 0.542, P < 0.001); TPO inhibited 42% of IgE binding to EPX, while EPX inhibited 59% of IgE binding to TPO, suggesting a cross-reactivity with EPX as a primary sensitizer. There was greater inhibition when we used a pool of sera CSU and AD, TPO inhibited 52% of IgE binding to EPX, while EPX inhibited 78% of IgE binding to TPO. In silico analysis showed a possible shared epitope in the peroxidase protein family. Conclusions: IgE against eosinophil proteins may contribute to chronic inflammation in patients with AD and CSU. Cross-reactivity between EPX and TPO could explain thyroid problems in CSU patients.spa
dc.format.extent16 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherKorean Academy of Asthma, Allergy and Clinical Immunologyspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttps://creativecommons.org/licenses/by-nc/2.5/co/*
dc.titlePresence of IgE Autoantibodies Against Eosinophil Peroxidase and Eosinophil Cationic Protein in Severe Chronic Spontaneous Urticaria and Atopic Dermatitisspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupCentro de de Investigaciones Dermatológicasspa
dc.publisher.groupGrupo de Alergología Clínica y Experimental (GACE)spa
dc.identifier.doi10.4168/aair.2021.13.5.746-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2092-7363-
oaire.citationtitleAllergy, Asthma and Immunology Researchspa
oaire.citationstartpage746spa
oaire.citationendpage761spa
oaire.citationvolume13spa
oaire.citationissue5spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc/4.0/spa
oaire.fundernameUniversidad de Antioquiaspa
oaire.fundernameHospital Universitario de San Vicente Fundaciónspa
dc.publisher.placeSeúl, Corea del Surspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsDermatitis Atópica-
dc.subject.decsDermatitis, Atopic-
dc.subject.decsAutoanticuerpos-
dc.subject.decsAutoantibodies-
dc.subject.decsInmunoglobulina E-
dc.subject.decsImmunoglobulin E-
dc.subject.decsUrticaria Crónica-
dc.subject.decsChronic Urticaria-
dc.subject.decsAlergia e Inmunología-
dc.subject.decsAllergy and Immunology-
dc.subject.decsPeroxidasa del Eosinófilo-
dc.subject.decsEosinophil Peroxidase-
dc.subject.decsProteína Catiónica del Eosinófilo-
dc.subject.decsEosinophil Cationic Protein-
dc.description.researchgroupidCOL0059567spa
dc.description.researchgroupidCOL0130733spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D003876-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D001323-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D007073-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000080223-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000486-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D047209-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D047150-
dc.relation.ispartofjournalabbrevAllergy Asthma Immunol. Res.spa
oaire.funderidentifier.rorRoR:03bp5hc83-
oaire.funderidentifier.rorRoR:059ebsr57-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
SanchezJorge_2021_Presence_IgE_Autoantibodies.pdfArtículo de investigación2.8 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons